161 related articles for article (PubMed ID: 7933089)
21. The promoter activity of long terminal repeats of the HERV-H family of human retrovirus-like elements is critically dependent on Sp1 family proteins interacting with a GC/GT box located immediately 3' to the TATA box.
Sjøttem E; Anderssen S; Johansen T
J Virol; 1996 Jan; 70(1):188-98. PubMed ID: 8523525
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region.
Butz K; Hoppe-Seyler F
J Virol; 1993 Nov; 67(11):6476-86. PubMed ID: 8411351
[TBL] [Abstract][Full Text] [Related]
23. trans activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors.
Ushikai M; Lace MJ; Yamakawa Y; Kono M; Anson J; Ishiji T; Parkkinen S; Wicker N; Valentine ME; Davidson I
J Virol; 1994 Oct; 68(10):6655-66. PubMed ID: 8083999
[TBL] [Abstract][Full Text] [Related]
24. The bovine papillomavirus 1 E2 protein contains two activation domains: one that interacts with TBP and another that functions after TBP binding.
Steger G; Ham J; Lefebvre O; Yaniv M
EMBO J; 1995 Jan; 14(2):329-40. PubMed ID: 7835344
[TBL] [Abstract][Full Text] [Related]
25. Multiple transcription factor binding sites mediate adenovirus E1A transactivation.
Pei R; Berk AJ
J Virol; 1989 Aug; 63(8):3499-506. PubMed ID: 2545919
[TBL] [Abstract][Full Text] [Related]
26. Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription.
Li R; Knight JD; Jackson SP; Tjian R; Botchan MR
Cell; 1991 May; 65(3):493-505. PubMed ID: 1850324
[TBL] [Abstract][Full Text] [Related]
27. Low-affinity E2-binding site mediates downmodulation of E2 transactivation of the human papillomavirus type 8 late promoter.
Stubenrauch F; Pfister H
J Virol; 1994 Nov; 68(11):6959-66. PubMed ID: 7933077
[TBL] [Abstract][Full Text] [Related]
28. The E8 repression domain can replace the E2 transactivation domain for growth inhibition of HeLa cells by papillomavirus E2 proteins.
Stubenrauch F; Straub E; Fertey J; Iftner T
Int J Cancer; 2007 Nov; 121(10):2284-92. PubMed ID: 17583574
[TBL] [Abstract][Full Text] [Related]
29. The adeno-associated virus type 2 p40 promoter requires a proximal Sp1 interaction and a p19 CArG-like element to facilitate Rep transactivation.
Pereira DJ; Muzyczka N
J Virol; 1997 Jun; 71(6):4300-9. PubMed ID: 9151818
[TBL] [Abstract][Full Text] [Related]
30. Activation of a heterologous promoter by human immunodeficiency virus type 1 Tat requires Sp1 and is distinct from the mode of activation by acidic transcriptional activators.
Kamine J; Subramanian T; Chinnadurai G
J Virol; 1993 Nov; 67(11):6828-34. PubMed ID: 8411386
[TBL] [Abstract][Full Text] [Related]
31. Activation of the adenovirus major late promoter by transcription factors MAZ and Sp1.
Parks CL; Shenk T
J Virol; 1997 Dec; 71(12):9600-7. PubMed ID: 9371624
[TBL] [Abstract][Full Text] [Related]
32. Regulation of the human mitotic centromere-associated kinesin (MCAK) promoter by the transcription factors Sp1 and E2F1.
Jun DY; Park HS; Lee JY; Kim YH
Biochim Biophys Acta; 2008 May; 1779(5):356-61. PubMed ID: 18440323
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16.
Desaintes C; Hallez S; Van Alphen P; Burny A
J Virol; 1992 Jan; 66(1):325-33. PubMed ID: 1309249
[TBL] [Abstract][Full Text] [Related]
34. p53-Dependent and -independent transactivation by the E6 protein of human papillomavirus type 16.
Akutsu N; Shirasawa H; Asano T; Isono K; Simizu B
J Gen Virol; 1996 Mar; 77 ( Pt 3)():459-63. PubMed ID: 8601782
[TBL] [Abstract][Full Text] [Related]
35. Sp1 is a key regulator of the PDGF beta-receptor transcription.
Molander C; Hackzell A; Ohta M; Izumi H; Funa K
Mol Biol Rep; 2001; 28(4):223-33. PubMed ID: 12153142
[TBL] [Abstract][Full Text] [Related]
36. Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells.
Francis DA; Schmid SI; Howley PM
J Virol; 2000 Mar; 74(6):2679-86. PubMed ID: 10684283
[TBL] [Abstract][Full Text] [Related]
37. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT).
Kyo S; Takakura M; Taira T; Kanaya T; Itoh H; Yutsudo M; Ariga H; Inoue M
Nucleic Acids Res; 2000 Feb; 28(3):669-77. PubMed ID: 10637317
[TBL] [Abstract][Full Text] [Related]
38. Functional analyses of natural variation in Sp1 binding sites of a TATA-less promoter.
Segal JA; Barnett JL; Crawford DL
J Mol Evol; 1999 Dec; 49(6):736-49. PubMed ID: 10594175
[TBL] [Abstract][Full Text] [Related]
39. E7 proteins of four groups of human papillomaviruses, irrespective of their tissue tropism or cancer association, possess the ability to transactivate transcriptional promoters E2F site dependently.
Hiraiwa A; Kiyono T; Suzuki S; Ohashi M; Ishibashi M
Virus Genes; 1996; 12(1):27-35. PubMed ID: 8879118
[TBL] [Abstract][Full Text] [Related]
40. Promoter activity and distance constraints of one versus two Sp1 binding sites.
Segal R; Berk AJ
J Biol Chem; 1991 Oct; 266(30):20406-11. PubMed ID: 1939095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
